It is possible TAMs are not the dominant effector cell of small molecule STING agonists in this model and STING signaling occurs via other cell populations such as tumor resident DCs (21), endothelial cells (19) or remaining macrophage pools. This evidence concerns the gene STING1 and neoplasm.